Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-29 7:40 pm Purchase | 13D | Panbela Therapeutics Inc. PBLA | Nant Capital LLC | 2,427,066 33.330% | 2,427,066 (New Position) | View |
2024-02-13 8:10 pm Unchanged | 13G | Panbela Therapeutics Inc. PBLA | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | View |
2023-02-14 2:45 pm Sale | 13G | Panbela Therapeutics Inc. PBLA | Cullen Michael T. | 35,053 3.300% | -838,265 (-95.99%) | View |
2023-01-30 4:38 pm Purchase | 13G | Panbela Therapeutics Inc. PBLA | Lind Global Fund II LP | 590,000 9.900% | 590,000 (New Position) | View |
2022-02-14 5:20 pm Purchase | 13G | Panbela Therapeutics Inc. PBLA | Cullen Michael T. | 873,318 6.300% | 46,047 (+5.57%) | View |
2021-02-16 4:06 pm Purchase | 13G | Panbela Therapeutics Inc. PBLA | Cullen Michael T. | 827,271 8.200% | 827,271 (New Position) | View |
2021-02-16 4:01 pm Purchase | 13G | Panbela Therapeutics Inc. PBLA | Schemel Donald Robert | 450,624 4.600% | 450,624 (New Position) | View |
2020-09-08 5:15 pm Purchase | 13G | Panbela Therapeutics Inc. PBLA | ARMISTICE CAPITAL LLC | 497,029 4.990% | 497,029 (New Position) | View |
2020-02-14 07:32 am Purchase | 13G | Panbela Therapeutics Inc. PBLA | Schemel Donald Robert | 408,049 6.200% | 3,400 (+0.84%) | View |
2020-02-14 07:22 am Purchase | 13G | Panbela Therapeutics Inc. PBLA | Cullen Michael T. | 746,571 11.300% | 157,495 (+26.74%) | View |